Bio-Techne Corp is a global biotechnology company that develops, manufactures, and sells instruments, reagents, custom manufacturing, and testing services for the researchers in the life science and clinical diagnostics markets. The firm is incorporated in Minneapolis, Minnesota, and has been in operation since 1976. The firm employs more than 2,600 people worldwide and has over 500,000 products on the market.
The firm owns and operates a number of brands in the biotechnology industry. Brands include R&D Systems, which is involved in the development of high-quality proteins, antibodies, arrays, stem cell products, and cell selection and detection products, and Novus Biologicals, which is engaged in the production, licencing, and marketing of antibodies in niche and emerging research markets. The company also owns Tocris, the leading supplier of novel, exclusive small molecules and peptides for use in life science research.
The company’s therapeutic manufacturing branch creates products in the areas of cell and gene therapy, immune-oncology, and protein bioprocessing. Services offered include custom antibody services, cell and gene therapy services, and custom compound library services. Bio-Techne Corp is listed on the NASDAQ, where it trades under the stock ticker TECH.
Diversify your virtual portfolio by following TECH shares using your eToro watchlist.